Aerovate Therapeutics Statistics
Total Valuation
HKG:1894 has a market cap or net worth of HKD 27.63 million. The enterprise value is -3.38 million.
Market Cap | 27.63M |
Enterprise Value | -3.38M |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HKG:1894 has 921.12 million shares outstanding. The number of shares has increased by 15.67% in one year.
Current Share Class | 921.12M |
Shares Outstanding | 921.12M |
Shares Change (YoY) | +15.67% |
Shares Change (QoQ) | +7.82% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.15 |
PB Ratio | 0.19 |
P/TBV Ratio | 0.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 0.14 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 0.06 |
Financial Position
The company has a current ratio of 6.66, with a Debt / Equity ratio of 0.00.
Current Ratio | 6.66 |
Quick Ratio | 5.16 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | -0.00 |
Interest Coverage | -1,753.10 |
Financial Efficiency
Return on equity (ROE) is -15.77% and return on invested capital (ROIC) is -7.19%.
Return on Equity (ROE) | -15.77% |
Return on Assets (ROA) | -6.16% |
Return on Invested Capital (ROIC) | -7.19% |
Return on Capital Employed (ROCE) | -11.94% |
Revenue Per Employee | 468,793 |
Profits Per Employee | -60,030 |
Employee Count | 400 |
Asset Turnover | 1.05 |
Inventory Turnover | 7.72 |
Taxes
In the past 12 months, HKG:1894 has paid 693,000 in taxes.
Income Tax | 693,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.54% in the last 52 weeks. The beta is 0.04, so HKG:1894's price volatility has been lower than the market average.
Beta (5Y) | 0.04 |
52-Week Price Change | +11.54% |
50-Day Moving Average | 0.03 |
200-Day Moving Average | 0.03 |
Relative Strength Index (RSI) | 48.14 |
Average Volume (20 Days) | 1,760,750 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1894 had revenue of HKD 187.52 million and -24.01 million in losses. Loss per share was -0.03.
Revenue | 187.52M |
Gross Profit | 2.57M |
Operating Income | -17.53M |
Pretax Income | -23.32M |
Net Income | -24.01M |
EBITDA | -13.65M |
EBIT | -17.53M |
Loss Per Share | -0.03 |
Balance Sheet
The company has 31.09 million in cash and 81,000 in debt, giving a net cash position of 31.01 million or 0.03 per share.
Cash & Cash Equivalents | 31.09M |
Total Debt | 81,000 |
Net Cash | 31.01M |
Net Cash Per Share | 0.03 |
Equity (Book Value) | 144.51M |
Book Value Per Share | 0.16 |
Working Capital | 117.15M |
Cash Flow
In the last 12 months, operating cash flow was -50.05 million and capital expenditures -5.65 million, giving a free cash flow of -55.69 million.
Operating Cash Flow | -50.05M |
Capital Expenditures | -5.65M |
Free Cash Flow | -55.69M |
FCF Per Share | -0.06 |
Margins
Gross margin is 1.37%, with operating and profit margins of -9.35% and -12.81%.
Gross Margin | 1.37% |
Operating Margin | -9.35% |
Pretax Margin | -12.44% |
Profit Margin | -12.81% |
EBITDA Margin | -7.28% |
EBIT Margin | -9.35% |
FCF Margin | n/a |
Dividends & Yields
HKG:1894 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -15.67% |
Shareholder Yield | -15.67% |
Earnings Yield | -86.89% |
FCF Yield | -201.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HKG:1894 has an Altman Z-Score of 2.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.19 |
Piotroski F-Score | 2 |